Markel Group’s Labcorp LH Stock Holding History

Markel Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-17,460	Closed	-$1.53M	–	109
2014 Q3	$1.53M	Hold	17,460	–	–	0.04%	97
2014 Q2	$1.54M	Buy	+17,460	New	+$1.51M	0.04%	95

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

PIM

Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return

Markel Group's LH Position: Q4 2014 in Review

Markel Group sold out of Labcorp (LH) in Q4 2014, closing a stake of 17,460 shares — an estimated $1.53M sold.

Markel Group first reported a position in LH in Q2 2014 and held it in 2 quarters. The position peaked at $1.54M in Q2 2014. 553 funds tracked by Wall St. Rank hold LH as of Q4 2014.

Markel Group reported no remaining Labcorp position as of Q4 2014 after selling out during the quarter.
Markel Group sold 17,460 Labcorp shares in Q4 2014, an estimated $1.53M.
Markel Group first reported a position in Labcorp in Q2 2014 and held it in 2 quarters.
Markel Group's Labcorp position peaked at $1.54M in Q2 2014.
553 funds tracked by Wall St. Rank held Labcorp as of Q4 2014.

Based on Markel Group's 13F filing for Q4 2014, filed 9 Feb 2015.